Chloe Ramirez
Thimerosal, a mercury-based preservative, has been used in vaccines since the 1930s. It is added to multi-dose vials to prevent the growth of harmful bacteria and fungi, which can enter when a syringe needle pierces the vial. While thimerosal has been deemed safe, with no evidence of harmful side effects, it has been phased out of many vaccines due to public concern and the development of single-dose presentations. Today, most vaccines do not contain thimerosal, and detailed research has shown that it does not cause neurodevelopmental disorders. However, some vaccines, such as those for influenza and yellow fever, may still contain trace amounts of thimerosal if it was used in the production process.
| Characteristics | Values |
|---|---|
| Mercury-based preservative used in vaccines | Thimerosal (also known as mercurothiolate and sodium 2-ethylmercuriothio-benzoate) |
| Thimerosal use since | 1930s |
| Thimerosal composition | Approximately 50% mercury by weight |
| Thimerosal use cases | Thimerosal has been used in some immune globulin preparations, anti-venins, skin test antigens, and ophthalmic and nasal products, in addition to some vaccines |
| Thimerosal reduction/elimination | In 1999, the AAP and the U.S. Public Health Service issued a joint statement recommending the reduction or elimination of thimerosal from vaccines as a precautionary measure |
| Thimerosal side effects | No evidence of harm caused by low doses of thimerosal in vaccines, except for minor reactions like redness, swelling, and pain at the injection site |
| Thimerosal and autism | Studies have found no association between thimerosal exposure and autism or neuropsychological delays |
| Thimerosal removal from vaccines | Thimerosal has already been removed from all childhood vaccines, and its use has declined in influenza vaccines |
| Thimerosal-containing vaccines | Diphtheria, tetanus, pertussis (DTP), diphtheria and tetanus toxoids (DT), tetanus toxoid (TT), hepatitis B, Haemophilus influenzae type b (Hib), and influenza |
Explore related products
What You'll Learn
- Thimerosal is a mercury-based preservative used in vaccines since the 1930s
- Thimerosal is approximately 50% mercury by weight and is cleared from the body quickly
- Its use has declined due to the development of single-dose vaccines that don't require preservatives
- There is no evidence of harm from Thimerosal, except minor reactions like redness and swelling
- Studies have found no link between Thimerosal and autism spectrum disorder (ASD)
Thimerosal is a mercury-based preservative used in vaccines since the 1930s
Thimerosal is a mercury-based preservative that has been used in vaccines since the 1930s. It is an organic compound that is approximately 50% mercury by weight. It is added to multi-dose vials of vaccines to prevent the growth of harmful microbes and bacteria, thus facilitating safe and effective immunization campaigns.
Thimerosal has been widely used in biological and drug products, including vaccines, to prevent microbial contamination. Its antimicrobial properties are particularly useful in multi-dose vials, where there is a risk of introducing harmful microbes during each use. This preservative helps to prevent bacterial and fungal contamination, which could lead to severe local reactions, serious illnesses, or even death.
While thimerosal has been deemed safe for use in vaccines, concerns have been raised about potential links to neurodevelopmental disorders, specifically autism, ADHD, and speech or language delays. However, studies have found no association between thimerosal exposure and these disorders. The CDC and FDA have concluded that the evidence does not support a link between thimerosal-containing vaccines and autism.
In recent years, the use of thimerosal has declined due to the development of single-dose vaccines that do not require preservatives. Additionally, alternative preservatives like phenol are now used in some FDA-approved vaccines. Thimerosal is no longer used in childhood vaccines in the United States, and flu vaccines are available in both thimerosal-containing and thimerosal-free versions.
Vaccine Hesitancy: Political Divide on Shots
You may want to see also
Explore related products
Thimerosal is approximately 50% mercury by weight and is cleared from the body quickly
Thimerosal, a mercury-based preservative, has been used for decades in the United States in multi-dose vials of medicines and vaccines. It is approximately 50% mercury by weight. It is metabolized or degraded to ethylmercury and thiosalicylate. Ethylmercury is processed differently in the body and is less likely to build up in the body. It is cleared from the body more quickly than methylmercury, the type of mercury found in certain kinds of fish, and is therefore less likely to cause harm.
Thimerosal has been used to prevent the growth of harmful microbes inadvertently introduced into the vaccine during use. It has been shown to be effective in clearing a broad spectrum of pathogens. A vaccine containing 0.01% thimerosal as a preservative contains 50 micrograms of thimerosal per 0.5 mL dose or approximately 25 micrograms of mercury per 0.5 mL dose. This is roughly the same amount of elemental mercury contained in a 3-ounce can of tuna fish.
The use of thimerosal has declined in recent years due to the development of new products formulated into single-dose presentations that do not require preservatives. In 1999, the Public Health Service agencies, the American Academy of Pediatrics, and vaccine manufacturers agreed that thimerosal should be reduced or eliminated in vaccines as a precautionary measure. As of 2024, thimerosal has been removed from all childhood vaccines, and it is no longer used in vaccines for children under the age of 6. However, it is still used in some flu vaccines for adults.
Studies have shown that thimerosal exposure is not associated with an increased risk of autism spectrum disorder (ASD) or neuropsychological delays. While some people believe that increased exposure to thimerosal may explain the higher prevalence of autism, evidence from several studies does not support such a link.
Pneumococcal Vaccines: Are They Covered in BC?
You may want to see also
Explore related products
Its use has declined due to the development of single-dose vaccines that don't require preservatives
Thimerosal, a mercury-based preservative, has been used in vaccines since the 1930s. It is added to vials of vaccines containing more than one dose (multi-dose vials) to prevent the growth of harmful microbes inadvertently introduced into the vaccine during use, which can cause severe local reactions, serious illness, or even death.
However, in recent years, the use of mercury-containing preservatives like thimerosal has declined due to the development of single-dose vaccines that do not require preservatives. This decline is attributed to the reformulation of vaccines and their supply in single-use presentations.
The development of single-dose vaccines offers several advantages. Firstly, they eliminate the need for preservatives, addressing concerns about the potential risks associated with mercury-based preservatives, such as thimerosal. While studies have shown that the low doses of thimerosal in vaccines have no harmful effects other than minor local reactions, such as redness and swelling at the injection site, the decline in its use aligns with the precautionary measures agreed upon in 1999.
Secondly, single-dose vaccines have the potential to maximize vaccination coverage, reduce costs associated with vaccination, and improve patient convenience. They streamline vaccination schedules and reduce the number of doses required to achieve adequate protection. This progression towards single-dose vaccines is an active area of research, with scientists exploring innovative technologies and approaches to develop potent and effective single-dose vaccines.
It is important to note that the decline in mercury-containing preservatives in vaccines does not indicate their complete elimination. Some vaccines, such as those for seasonal and pandemic influenza, continue to be packaged in multi-dose vials with thimerosal as a preservative. Additionally, thimerosal is still used in some immune globulin preparations, anti-venins, skin test antigens, and ophthalmic and nasal products.
Smokers' Eligibility for Illinois Vaccination
You may want to see also
Explore related products
There is no evidence of harm from Thimerosal, except minor reactions like redness and swelling
Thimerosal is a mercury-based preservative that has been used for decades in the United States in multi-dose vials of medicines and vaccines. It is added to vials of vaccines that contain more than one dose to prevent the growth of harmful microbes inadvertently introduced into the vaccine during use. It is also added during the manufacturing process to prevent germ growth.
Thimerosal has been the subject of numerous studies, and while it is approximately 50% mercury by weight, there is no evidence of harm caused by the low doses of thimerosal in vaccines, except for minor reactions like redness and swelling at the injection site. The most common side effects of thimerosal in vaccines are these minor reactions, and although rare, some people may be allergic to thimerosal. Research does not show any link between thimerosal in vaccines and autism, a neurodevelopmental disorder. Many well-conducted studies have concluded that thimerosal in vaccines does not contribute to the development of autism.
In 1999, the FDA determined that under the recommended childhood immunization schedule, infants might be exposed to cumulative doses of ethylmercury that exceed some federal safety guidelines established for ingestion of methylmercury, another form of organic mercury. This led to the American Academy of Pediatrics (AAP) and the U.S. Public Health Service (PHS) issuing a joint statement recommending the removal of thimerosal from vaccines as soon as possible. The statement also recommended a temporary suspension of the birth dose of the hepatitis B vaccine for children born to low-risk mothers until a thimerosal-free alternative became available.
The use of mercury-containing preservatives has declined in recent years due to the development of new products formulated into single-dose presentations that do not require preservatives. However, thimerosal is still added to some vaccines, and the benefits of flu vaccination are considered to outweigh any risk from thimerosal exposure.
Premature Babies: Different Vaccination Needs?
You may want to see also
Explore related products
Studies have found no link between Thimerosal and autism spectrum disorder (ASD)
Thimerosal, a preservative used in vaccine formulations, is approximately 50% mercury by weight. It is added to multi-dose vials of vaccines to prevent the growth of harmful microbes and bacteria and fungi contamination.
Despite its long record of safe and effective use, concerns have been raised about Thimerosal's potential link to autism spectrum disorder (ASD). Some people believe that increased exposure to Thimerosal from childhood vaccines may explain the higher prevalence of autism in recent years. However, multiple studies have found no evidence to support this association.
A 2010 study by the Centers for Disease Control and Prevention (CDC) showed that prenatal and infant exposure to vaccines and immunoglobulins containing Thimerosal does not increase the risk for ASD. The study also found no association between Thimerosal exposure and neuropsychological delays. Similarly, an Italian study found that immunization in infancy with Thimerosal-containing vaccines does not negatively impact neuropsychological performance later in childhood.
In 2004, the Immunization Safety Review Committee of the Institute of Medicine (IOM) rejected the hypothesis of a causal relationship between Thimerosal-containing vaccines and autism. The IOM reviewed over 200 scientific studies and consistently found no association between Thimerosal-containing vaccines and autism. Additionally, the FDA concluded in 2004 that the evidence does not support an association between Thimerosal-containing vaccines and autism.
While the use of Thimerosal as a preservative in vaccines has declined due to the development of single-dose presentations, it is important to note that Thimerosal has been deemed safe for use in vaccines, and the benefits of vaccination outweigh any potential risks.
mRNA Vaccines: Gene Therapy or Not?
You may want to see also
Frequently asked questions
Thimerosal, a mercury-based preservative, has been used for decades in the United States in multi-dose vials of vaccines. However, due to concerns about mercury toxicity, its use has significantly declined in recent years. Most vaccines today do not contain thimerosal, and it has been removed from all childhood vaccines.
Thimerosal is an effective antiseptic that prevents the growth of harmful fungi and bacteria in vaccines, especially during the use of opened multi-dose vials. This helps to maintain the sterility of the vaccine and prevent contamination that could lead to severe local reactions, serious illness, or even death.
Thimerosal in vaccines has been shown to be safe, with no evidence of harmful effects beyond minor local reactions such as redness and swelling at the injection site. Studies have found no association between thimerosal exposure and neuropsychological delays or an increased risk of autism spectrum disorder (ASD).
In 1999, the American Academy of Pediatrics (AAP) and the U.S. Public Health Service recommended removing thimerosal from childhood vaccines as a precautionary measure. This decision was made out of an abundance of caution due to concerns about potential risks associated with mercury exposure, particularly in premature infants and children of mothers who consumed large amounts of fish.
While thimerosal has been phased out of most vaccines, it is still present in some influenza vaccines in multi-dose vials. However, detailed research has shown that thimerosal does not cause neurodevelopmental disorders, and the benefits of flu vaccination are considered to outweigh any risks from thimerosal exposure.
